Novel NK-3 receptor selective antagonist compounds, pharmaceutical composition and methods for use in NK-3 receptors mediated disorders

Details for Australian Patent Application No. 2011234398 (hide)

Owner Euroscreen S.A.

Inventors Hoveyda, Hamid; Roy, Marie-Odile; Fraser, Graeme Lovat; Dutheuil, Guillaume

Agent Griffith Hack

Pub. Number AU-A-2011234398

PCT Pub. Number WO2011/121137

Priority 10305343.5 02.04.10 EP; 61/379 028 01.09.10 US

Filing date 4 April 2011

Wipo publication date 6 October 2011

International Classifications

C07D 487/04 Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups

A61K 31/495 - having six-membered rings with two nitrogen atoms as the only ring hetero atoms, e.g. piperazine

A61P 25/00 Drugs for disorders of the nervous system

A61P 29/00 Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

Event Publications

13 September 2012 PCT application entered the National Phase

  PCT publication WO2011/121137 Priority application(s): WO2011/121137

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2011234415-Bioadhesive compositions of local anaesthetics

2011234396-Solving character display ambiguities